|Dr. Ross Thomas Murdoch Ph.D.||Chief Exec. Officer, Managing Director and Exec. Director||459.4k||N/A||52|
|Ms. Anna Legg||Chief Financial Officer and Company Sec.||N/A||N/A||N/A|
|Dr. Paul Gavin BSc (Hons), Ph.D.||Chief Scientific Officer||N/A||N/A||N/A|
|Dr. Roksan Libinaki BSc (Biomed) (Hons), Ph.D.||Gen. Mang. of Animal Health and Nutrition||N/A||N/A||N/A|
|Mr. Greg Moses||Gen. Mang. of Production and Personal Care||N/A||N/A||N/A|
Phosphagenics Limited, a research-based biotechnology company, produces, sells, and licenses products using its proprietary Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production and Personal Care, and Human Health segments. It manufactures and sells TPM and Vital ET solutions for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The companys human health portfolio covers delivery of drugs through gels, injectables, and patches. It serves customers in Australia, Switzerland, the United States, India, Brazil, and other countries. The company was formerly known as Vital Capital Limited and changed its name to Phosphagenics Limited in 2004. Phosphagenics Limited is based in Clayton, Australia.
Phosphagenics Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.